Aurora Cannabis (ACB) Cost of Revenue (2017 - 2026)

Aurora Cannabis (ACB) has reported Cost of Revenue for 10 consecutive years, with $63.1 million the latest figure, recorded in Q1 2026.

• Quarterly Cost of Revenue rose 1.44% year-over-year to $63.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $182.1 million (down 91.54% YoY) and the FY2026 annual result came in at $133.1 million, up 71.39% from the prior year.
• Cost of Revenue advanced to $63.1 million in Q1 2026 per ACB's latest filing, from $34.4 million in the prior quarter.
• Over the last five years, Cost of Revenue for ACB reached as high as $5.1 billion in Q2 2023 and fell as low as $15.6 million in Q1 2024.
• A 5-year average of $602.8 million and a median of $46.2 million in 2022 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2023 — Cost of Revenue surged 14137.49% — and 2024, when it slumped 99.21%.
• Year by year, Cost of Revenue stood at $110.1 million in 2022, then slumped by 70.8% to $32.2 million in 2023, then slipped by 0.13% to $32.1 million in 2024, then climbed by 7.2% to $34.4 million in 2025, then soared by 83.22% to $63.1 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $63.1 million, $34.4 million, and $39.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.